肺腺癌中的Sirtuin家族
Cui Chen1, Xiumin Liu1, Zhe Xu1
1Qujing Medical College, Qujing, 655011, Yunnan Province, China.
Discover oncology
|July 23, 2025
概括
本综述详细介绍了Sirtuins在肺腺癌 (LUAD),一种常见的癌症中的作用. 它探讨了Sirtuin的功能及其在LUAD治疗中的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 肺腺癌 (LUAD) 是全球癌症死亡的主要原因.
- 赛尔图因 (SIRT) 是一类依赖NAD+的脱乙酶,它们参与关键的细胞过程.
- 现有的关于Sirtuins和肺癌的评论缺乏对LUAD的具体关注.
研究的目的:
- 阐明在LUAD中Sirtuins (SIRT1-7) 的特定作用和机制.
- 审查目前关于Sirtuin参与LUAD病变的理解.
- 讨论在LUAD中针对sirtuins的治疗潜力.
主要方法:
- 关于sirtuins和LUAD的研究的综合文献综述.
- 对细胞分化,细胞亡,新陈代谢和自相关的Sirtuin功能的分析.
- 对癌症治疗中Sirtuin抑制剂和激活剂的临床前和临床数据的检查.
主要成果:
- 赛尔图因在LUAD中表现出多种作用,影响瘤生长,转移和对治疗的反应.
- 特定的Sirtuins (例如,SIRT1,SIRT3,SIRT7) 已涉及促进或抑制LUAD进展.
- 赛尔图因活性失调是LUAD的标志性特征,提供潜在的治疗途径.
结论:
- 赛尔图因代表了LUAD有前途的治疗点.
- 通过抑制剂或激活剂调节Sirtuin活性,可以为LUAD患者提供新的治疗策略.
- 为了优化治疗干预措施,需要对LUAD中的Sirtuin特定机制进行进一步的研究.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.5K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
543
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
01:12Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K